TAYLOR SCHILLING: Open Payments
NPI 1639932767 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 58 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,630
Food & beverage: $1,630
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $224 |
| SCPHARMACEUTICALS INC. | 6 | $214 |
| Amgen Inc. | 9 | $156 |
| Edwards Lifesciences Corporation | 1 | $148 |
| Merck Sharp & Dohme LLC | 2 | $140 |
| Novo Nordisk Inc | 5 | $138 |
| Abbott Laboratories | 1 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| PFIZER INC. | 4 | $72 |
Products named: LifeVest, FUROSCIX, ELIQUIS, REPATHA, SAPIEN 3 Ultra RESILIA, Wegovy, WINREVAIR, CARDIOMEMS.
Industry payments across SC — which companies pay providers there.
